Pharma exec Shkreli out on $5M bail after pleading not guilty to securities fraud
The bond consists of funds and other collateral posted by Martin Shkreli, and two relatives and other associates who appeared in court with him. Shkreli said nothing in court beyond identifying himself, indicating he understood the criminal charges and entering a not guilty plea. Previously criticized for raising the price of life-saving drugs such as those used to fight HIV and cancer, he was arrested early Thursday in New York City and indicted on criminal and civil securities fraud charges. Ref. USAToday
Image from Wikimedia public domain.
Martin Shkreli (Hover)
'USA's most hated man' arrested
MARTIN Shkreli, the man who jacked up the price of a lifesaving drug to pad his pockets, has just been knocked off his perch. Ref. Source 1q
Martin Shkreli has stepped down as CEO of Turing Pharmaceuticals, the company said Friday.
Turing's main drug is Daraprim, the treatment for cancer and AIDS patients that made Shkreli a household name. Turing bought the drug in August and shortly after that, Shkreli announced he was raising the price of the drug by nearly 5,500% -- from $13.50 a pill to $750.
Federal prosecutors on Thursday indicted Shkreli on securities fraud charges for things he allegedly did at Retrophin, a biotech he founded in 2011 and was fired from last year. Ref. CNN
Former Turing CEO Martin Shkreli refuses to testify about controversy over 5,000% drug price hike
Shkreli pleaded the 5th Amendment after being forced to appear before a Congressional committee hearing Thursday about skyrocketing drug prices. Ref. USAToday.